DUBLIN, February 24, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/g7t5qt/vascular_closure) has announced the addition of the "Vascular Closure Devices (VCD) Global Market - Forecast to 2022" report to their offering.
Among the vascular closure products, the active approximators market dominated the products market by occupying a largest share in 2015. At the same time, the passive approximators market is also expected to grow at a high single digit CAGR from 2015 to 2022. Geographical wise North America is the largest market, followed by Europe and Asia Pacific.
The North America regions suggest an array of opportunities for growth and are likely to be getting into the eyes of new investors in the vascular closure market. Growth is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The Vascular closure market is expected to grow steadily in the forecast period. The factors driving the growth of this market are increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures. Ease in usage and quick hemostatic properties of VCDs and increased utilization of transradial arterial access are some of the opportunities that are propelling the growth of the market.
High price of products, complications associated with VCD, less adoption of novel technologies in emerging countries are hampering the market of vascular closure. Reduced reimbursement, usage of animal related sources and lower revenue potential of VCD are threats for the market growth.
Some of the key players of the vascular closure market are Abbott Laboratories (U.S.), Advanced Vascular Dynamics (U.S.), B Braun Melsungen AG (Germany), Biotronik Corpotation (Germany), C R Bard International (U.S.), Cardinal Health (U.S.), Cardiva medical (U.S.), Morris Innovative (U.S.), Scion Biomedical (U.S.), St Jude Medical (U.S.), Terumo Corporation (Japan) and Vascular Solutions, Inc (U.S.)
Key Topics Covered:
1 Executive Summary
3 Market Analysis
4 Vascular Closure Devices Global Market, By Type
5 Vascular Closure Devices Global Market, By Intervention
6 Vascular Closure Devices Global Market, By Access
7 Vascular Closure Devices Global Market, By Geography
8 Company Developments
9 Company Profiles
- Abbott Laboratories U.S.
- Advanced Vascular Dynamica U.S.
- Arstasis U.S.
- B. Braun Melsungen AG Germany
- Beijing PuYi Medical Technology Co., Ltd China
- Benrikal Services Canada
- Biotronik Corporation Germany
- C.R. Bard International U.S.
- CP Medical U.S.
- Cardinal Health U.S.
- CardioDex Israel
- Cardiva Medical U.S.
- Creganna Medical Ireland
- Endocor GmbH Germany
- Essential Medical Supplies U.S.
- Gambro Germany
- Hem Con medical technologies U.S.
- Hemoband corporation U.S.
- Inseal Medical Israel
- Liaoning Aimu Medical Science & Technology Co., Ltd China
- Maquet Holding B.V. & Co.KG Germany
- Marine Polymer Technologies U.S.
- Medeon Biodesign, Inc China
- Morris Innovative Inc U.S.
- Pressure product Inc U.S.
- Scion biomedical U.S.
- Sealantis Israel
- St Judes Medical Inc U.S.
- TZ Medical Inc U.S.
- Terumo Japan
- Transluminal Technologies, Inc U.S.
- Vascular Innovations Co Ltd Thailand
- Vivasure Medical Ireland
- W.L.Gore & Associates U.S.
- Z Medical
For more information visit http://www.researchandmarkets.com/research/g7t5qt/vascular_closure
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets